| abstract |
The present invention relates to a drug complex having an anti-cancer and anti-inflammatory activity, and relates to a drug complex comprising a RAGE-binding peptide, a disease-treating gene, and a cationic polymer. According to the present invention, it is possible not only to effectively interfere with the signal transduction system mediated by RAGE, but also to achieve a combined therapeutic effect of a peptide and a gene by including a gene for treating a disease, A drug complex capable of being produced can be provided. |